Spero Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year One in USD from Q4 2019 to Q4 2022
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
-
Summary
-
Spero Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year One history and growth rate from Q4 2019 to Q4 2022.
- Spero Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One for the quarter ending December 31, 2022 was $1.69M, a 24.1% increase year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year One, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year One, YoY Quarterly Growth (%)